Neuronetics Inc.

STIM | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.87

+$0.02 (+0.70%)

Sep 22, 2026, 11:06 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.70%

(1D)

Rating

Updated: Aug 18, 2026

38.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $199.37M

1D Range

2.73 2.87

52W Range

0.80 3.44

Valuation (TTM)

PE -6.63

PB 11.11

EV/EBITDA -12.49

Valuation (NTM)

Forward PE N/A

Forward PEG 0.33

Price Target $5

Cash Flow

FCF Yield -5.1%

SBC Adj. FCF Yield -8.1%

SBC Impact -59.1%

Margins

Gross Margin 49.1%

Operating Margin -14.7%

FCF Margin -6.5%

Growth (CAGR)

Revenue 3Y | 5Y 31.7% | 23.3%

Dil EPS 3Y | 5Y 38.6% | 18.6%

FCF 3Y | 5Y 35.6% | 17.5%

Returns

ROA -23.1%

ROE -150.6%

ROIC -21.1%

Financial Health

Net Debt

$42.09M

Current Ratio 1.88

Interest Coverage -2.67

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencin...

Sector Healthcare

Industry Medical - Devices

Employees 658

IPO Date Jun 27, 2018

Website www.neurostar.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+74.22%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞